Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Vectura Group Plc LSE:VEC London Ordinary Share GB00BKM2MW97 ORD 0.0271P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 103.40 104.80 106.20 105.60 102.00 102.00 491,403 16:35:29
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 160.5 -104.8 -13.2 - 624

Vectura Share Discussion Threads

Showing 10401 to 10423 of 10425 messages
Chat Pages: 417  416  415  414  413  412  411  410  409  408  407  406  Older
DateSubjectAuthorDiscuss
17/10/2020
22:59
I don't subscribe to law360.com.
polaris
15/10/2020
20:18
Nice Institutional buys which explains the massive volumes. This is a good confidence booster. Not to mention the broker forecast price of circa 130, which will likely be upgraded given the growth in this sector, coupled with renowned investors buys such as Robbie Burns who has added numerous positions. Buy at these prices while you still can, and buy, or add on the pullbacks as we head up. P
peddlers
15/10/2020
18:05
If there has been a seller ,suppressing our share price ,perhaps they have now sold out .Our track record with Vec suggests there will be little market reaction but will be interesting
base7
13/10/2020
17:10
I was feeling flush. thats me holding 10,210,000 now :-) P
peddlers
13/10/2020
17:02
2 Ordinary trades ( 5.1M each) went through at quarter to 4
peddlers
13/10/2020
16:33
Huge volume today - any rumours or news bubbling up?
bobo18
13/10/2020
13:41
I have heared in the past few days that the hospitals are inundated with cases but it is being greatly played down vs March
peddlers
13/10/2020
13:36
p Yes it looks very strong, I cannot understand why this is not surging higher, when the virus is based on respiratory problems, using the inhaler will be in high demand now than before covid started, no?
srpactive
13/10/2020
13:22
Chart is looking good. Might get a buying opportunity in the next few days.
peddlers
13/10/2020
08:59
We arent expecting to hear any more about our Advair Generic or case v GSK until early ( ish) next year ,unless, presumably, the Judges decide that a retrial should happen,in which case we may hear that (bad ) news sooner. Meanwhile, our other major JV with Hikma should be making progress & we will hopefully soon hear what the submission timetable is expected to be together with news on any collaborations/partnerships regarding the likelihood of our involvement in any C-19 solutions( we have 2 Directors who are non execs of Novact & Avacta) There must also be the possibility of Corporate action ( apart from options/rewards to our new senior management team ) , perhaps a bolt on acquisition to expand our involvement in the CDMS arena. Ever hopeful !
base7
12/10/2020
22:58
Vectura Limited v. GlaxoSimthKline LLC, No. 20-1054 This case involves U.S. Patent No. 8,303,991, relating to composite active particles comprising particles of active material and an additive material (e.g., magnesium stearate (“MgSt”)) on the surface of the particles. An asserted claim further requires that the additive material promotes the dispersion of the active particles upon actuation of a delivery device. Vectura filed suit alleging that GSK infringed the claim, and the jury found infringement. GSK then moved for judgement as a matter of law or a new trial, arguing that Vectura had not presented sufficient evidence that GSK’s accused products practiced the “dispersion221; limitation of the claim. The court rejected the argument. GSK asserts on appeal that it is entitled to judgment of noninfringement as a matter of law because experimentation by Vectura was required to prove that coating the active particles with MgSt improved dispersion, compared to products in which only carrier particles were coated with MgSt. GSK argues that Vectura conducted no dispersion tests on GSK’s accused products but merely extrapolated from a 2006 study of different experimental blends. According to GSK, in relying on the study, Vectura fails to meet its burden of proof because the experimental blends are not representative of GSK’s accused products. GSK also asserts that its products are made by a different method and contain ingredients absent from the study. In response, Vectura argues that no experimentation was required to prove infringement. According to Vectura, GSK itself conducted the study for testing the benefit to dispersal by coating the active particles and the carrier particles with MgSt. Vectura further asserts that the study showed that coating both types of particles with MgSt provided a three-fold increase in dispersion, as compared to coating only the carrier particles. Vectura claims that GSK itself concluded based on the study that the active particles “must be coated” with MgSt. According to Vectura, these asserted facts constitute substantial evidence of infringement. Vectura also argues that, in any event, GSK’s arguments about the differences between the study and the accused products were either fully presented to the jury and rejected, or never raised and therefore waived. hxxps://www.finnegan.com/en/insights/blogs/federal-circuit-ip/spotlight-on-upcoming-oral-arguments-october-2020.html#page=1
justiceforthemany
12/10/2020
22:54
x2 446,758 'off book' trades today at the offer price 106.2p suggesting buys.
justiceforthemany
12/10/2020
10:22
Another one trade, news soon possibly.
srpactive
12/10/2020
09:08
a53 Very good find, looks promising, we have a 1 trade so hopefully more news soon, the gsk outcome? dyor
srpactive
11/10/2020
22:47
Inhaled Vaccines Aim to Fight Coronavirus at Its Point of Attack: htTps://www.google.com/amp/s/www.bloombergquint.com/amp/onweb/covid-19-inhaled-vaccines-may-be-more-effective-than-injections
a1ord53
10/10/2020
09:15
Ah peddlers At my age just waking up in the the morning is positive for me .Yes do try to put some humour in at times don't do any analytical stuff as assume we all do our own research. Have a good weekend POB (Andrew )
pooroldboy55
09/10/2020
23:13
Poorold - Crikey lol, Are you having a bad day or is there a dark sense if humour in there? Stay positive old sport, this company is going up and you're going up with it. P
peddlers
09/10/2020
20:19
It was the bottom of the channel after all this week. I had to cancel my buy orders due to the Armenia-Azerbaijan conflict hurting my AAZ position and taking my spare margin. Traders will be looking to exploiting the range 100-120 p, IMO.
polaris
09/10/2020
19:31
What was the outcome of this weeks judicial review?
dp1umb
09/10/2020
19:16
This does seem to happen on Fridays for some reason don't worry usually disappears early Monday, but of course this time could be different.
pooroldboy55
09/10/2020
17:28
Unexpectedly firm close on average volume -most welcome ahead of the weekend
base7
09/10/2020
15:40
Tempted to add here
peddlers
09/10/2020
09:15
I do not know why gsk do not offer 130p to buy vec, then pay themselves the $200m. So it would be like buying vec for 100pps. dyor active
srpactive
Chat Pages: 417  416  415  414  413  412  411  410  409  408  407  406  Older
ADVFN Advertorial
Your Recent History
LSE
VEC
Vectura
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201020 21:50:55